Author:
Smith Anna Jo Bodurtha,Apple Annie,Hugo Audra,Haggerty Ashley,Ko Emily M.
Reference30 articles.
1. Controversies in Hereditary Cancer Management;Alhilli;Obstet Gynecol.,2021
2. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022;Armstrong;J. Natl. Compr. Canc Netw.,2022
3. Bills in 30 states show momentum to fix prior authorization | American Medical Association. Accessed November 28, 2023. https://www.ama-assn.org/practice-management/prior-authorization/bills-30-states-show-momentum-fix-prior-authorization.
4. Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis;Cadoo;Gynecol. Oncol.,2022
5. The Patient Experience of Prior Authorization for Cancer Care;Chino;JAMA Netw Open.,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献